Table 3.
The association between sTfR index and all-cause mortality among patients with CVD and cancer.
| All-cause mortality | CVD-related mortality | Cancer-related mortality | ||||
|---|---|---|---|---|---|---|
| HR (95%CI) | p-value | sHR (95% CI)a | p-value | sHR (95% CI)a | p-value | |
| Patients with CVD (N = 743) | ||||||
| Model 1 | 1.20 (0.97–1.48) | 0.103 | 1.27 (0.96–1.70) | 0.113 | 1.35 (0.87–2.10) | 0.272 |
| Model 2 | 1.23 (0.95–1.58) | 0.126 | 1.37 (0.92–2.03) | 0.498 | 1.74 (0.93–3.25) | 0.475 |
| Model 3 | 1.27 (0.91–1.77) | 0.168 | 1.53 (0.96–2.42) | 0.468 | 1.41 (0.77–2.56) | 0.578 |
| Patients with cancer (N = 728) | ||||||
| Model 1 | 1.11 (0.83–1.49) | 0.481 | 1.19 (0.73–1.95) | 0.515 | 1.01 (0.54–1.87) | 0.983 |
| Model 2 | 1.00 (0.67–1.49) | 0.994 | 0.48 (0.09–2.44) | 0.631 | 1.32 (0.70–2.47) | 0.638 |
| Model 3 | 1.12 (0.67–1.88) | 0.683 | 0.38 (0.07–2.13) | 0.580 | 1.46 (0.48–4.48) | 0.697 |
Model 1: unadjusted; model 2: adjusted for age, sex, ethnicity, smoking status, drinking status, and education; and model 3: further adjusted for BMI, SBP, DBP, albumin, total cholesterol, serum creatinine, serum potassium, hemoglobin, MCV, diabetes, hypertension, CVD, cancer, and ferritin.
a
Sub-distribution hazard ratio accounting for the competing event.